Cytogenetic analysis has identified 12p gain as the most frequent abnormality in human testicular germ cell tumors (TGCTs). It has been suggested that amplification and overexpression of stem cell-associated genes, including cyclin-D2, on the human chromosome 12p region are involved in germ cell tumorigenesis. By subtractive cDNA analysis, we identified Ddx1, a member of the DEAD-box protein family, as a gene predominantly expressed in the primordial germ cells of mouse embryos. Knockdown of Ddx1 in a mouse spermatogonia-derived cell line, GC-1spg, by short interference RNA repressed the expression of cyclin-D2, CD9 and GDF3 genes. In the mouse cyclin-D2 gene, a genomic DNA region between À348 and À329 was responsible for transcriptional activation by DDX1 based on reporter and gel shift assays. Similarly, DDX1 knockdown in the human TGCT cell line NEC8 repressed the expression of stem cell-associated genes localized on chromosome 12p13.3, including cyclin-D2, CD9 and NANOG. DDX1-knockeddown TGCT cells could not form solid tumors in nude mice. Furthermore, in situ hybridization revealed that DDX1 mRNA was produced in both seminoma and nonseminoma types of human TGCT samples. We conclude that DDX1 is a critical factor for testicular tumorigenesis.
Introduction
The testicular germ cell tumor (TGCT) is the most common malignancy in 20-to 34-year-old men (Bosl and Motzer, 1997) and accounts for approximately 1% of all cancers in men. The total number of testicular cancer patients in the world has more than doubled in the last 40 years. Male adult germ cell tumors comprise two major histological groups: seminomas and nonseminomas. Nonseminomas can be further divided into embryonal carcinoma, teratoma, yolk sac tumor and choriocarcinoma based on lineage differentiation. Nonseminomas frequently occur as mixed tumors consisting of two or more histological subtypes.
Gain of the chromosome arm 12p in human TGCTs was first described in 1982 (Atkin and Baker, 1982) . Chromosome 12 amplification has been demonstrated in testicular carcinomas in situ to be one of the earliest genetic changes to occur in these cancers (Chaganti and Houldsworth, 1998) . In contrast, other groups have reported that 12p gain is not an early event, but rather relates to the invasive growth of TGCTs (Rosenberg et al., 2000; Summersgill et al., 2001 ). An isochromosome of the short arm of chromosome 12, i(12p), has been proposed as a specific genetic marker of human TGCTs (Rodriguez et al., 1992) . The same group recently reported that among 101 TGCT specimens, stem cell-associated genes that localize on chromosome 12p13.3 are overexpressed in seminomas and embryonal carcinomas (Korkola et al., 2006) . The more abundantly the 12p stem cell genes are expressed, the less differentiated the TGCTs are in vivo.
Although 12p gain is the cytogenetic cause of TGCTs, it remains unknown how the expression of 12p stem cell genes is coordinately regulated in male germ line cells. DDX1 is a putative, ATP-dependent RNA helicase belonging to the DEAD-box family that is characterized by its Asp-Glu-Ala-Asp (DEAD) motif (Linder et al., 1989) . More than 40 DEAD-box proteins have been identified in a variety of species from bacteria to human (de Valoir et al., 1991; Linder, 2006) . In general, DEADbox protein family members are involved in RNA unwinding processes, such as translational initiation, mRNA splicing and ribosome assembly (Rocak and Linder, 2004) . However, as yet there is no evidence proving that DDX1 is involved in testicular development as a transcriptional activator.
Here, we demonstrated that DDX1 serves as a transcriptional activator of cyclin-D2 in a murine spermatogonia-derived cell line. Intriguingly, short interference RNA (siRNA)-mediated DDX1 knock-down in a human TGCT cell line repressed cyclin-D2 as well as other 12p genes whose functions are closely related to stem cell growth. These cells lost their anchorage-independence in vitro and their solid tumor formation in vivo, revealing that DDX1 is an important regulator for TGCTs.
Results

Identification of Ddx1 among primordial germ cell genes
We hypothesized that candidate oncogenes for TGCTs or their regulator genes can be identified among germ line stem cell-specific genes. Therefore, we first isolated genes that were predominantly expressed in the SSEA-1 þ primordial germ cells (PGCs), but not the SSEA-1 À somatic cells, of mouse male embryos at 13.5 days postcoitum (dpc) by a systematic screening with cDNA representational difference analysis (RDA) (Tanaka et al., 2002) . These genes included Dazl, which is expressed in both fetal and adult mouse male germ line stem cells, and Oct 3/4, an authentic marker gene for
PGCs. In addition, we also isolated Ddx1 (BC010624), Ube1y1 (AF150963), Ppx (AF088911) and Dppa5a (NM_025274). As expected, these gene-derived cDNA amplicons were almost exclusively present in the SSEA-1 þ cDNA fraction ( Figure 1a ; data not shown). As the function of DDX1 in male germ cells and TGCTs has not yet been explored, we investigated the expression of Ddx1 in the testis and its downstream effector molecules.
Expression of Ddx1 mRNA in the germ line stem cells of the mouse testis We first examined the mRNA expression of Ddx1 in various organs of the adult mouse. Northern blot analysis revealed that Ddx1 was most abundantly expressed in the testis and was barely detectable in other organs (Figure 1b) . We examined Ddx1 expression in the fetal gonad and in various stages of testicular development, and found that Ddx1 mRNA was continuously detectable from the sexually indifferent gonad at 11.5 dpc to the fetal testis at 19.5 dpc (Figure 1c, upper) . The expression level of Ddx1 in the testis was maintained after birth from 10 days post- Figure 1 Expression of Ddx1 mRNA and the DDX1 protein in male germ line stem cells during ontogeny of the mouse testis. (a) Equal amounts of PCR-amplified cDNA fragments derived from primordial germ cells (SSEA-1 þ ) or gonadal somatic cells (SSEA-1 À ) of E13.5 mouse embryos were subjected to Southern blot analysis using the indicated cDNA as a probe. Heat shock protein 8 (Hspa8, NP_112442) cDNA was used as a loading control. (b) Poly(A) þ RNA samples (10 mg each) from various organs of adult mice were subjected to northern blot analysis using mouse Ddx1 or GAPDH cDNA (loading control) as a probe. (c) Upper panel: various stages of fetal mouse gonads or testis were analysed by reverse transcriptase (RT)-PCR. DNA bands are shown after ethidium bromide staining. GAPDH was used to control for amounts of template cDNA. Lower panel: poly(A) þ RNA samples (1 mg each) of testis from various mouse ages were subjected to northern blot analysis using mouse Ddx1 or GAPDH cDNA (loading control) as a probe. (d) Male germ line stem cell fractions (c-Kit À Thy1 þ Integrin a6 þ ) and differentiated spermatogonial cell fractions (c-Kit þ ) were analysed by RT-PCR. DNA bands are shown after ethidium bromide staining. GAPDH was used to control for amounts of template cDNA. (e) Paraffin-embedded sections of testis from 12-week-old mice were subjected to immunohistochemical staining with (left) or without (right) an anti-DDX1 antibody. Positive signals appear as dark brown dots. Original magnification is Â 100.
Role of DDX1 in testicular tumorigenesis K Tanaka et al partum (dpp) through the 12-week-old adult stage (Figure 1c, lower) .
In the testes of mice at 7 dpp, Ddx1 mRNA was expressed in the c-Kit
þ integrin a6 þ germ line stem cell fraction (Kubota et al., 2003 (Kubota et al., , 2004 , but not in the c-Kit þ -differentiated spermatogonial cell fraction (Figure 1d ). Consistent with this, DDX1 proteinpositive cells localized near the basement membrane of the seminiferous tubule in adult mouse testes, where spermatogonial stem cells reside (Figure 1e, left) . The staining specificity of the anti-DDX1 antibody was confirmed by a control experiment in the absence of primary antibody (Figure 1e , right) and through western blotting (data not shown). The immunostaining intensity of DDX1 was decreased in spermatocytes under meiosis and was undetectable in the elongated spermatids in the central region of the testis (Figure 1e, left) . Taken together, these results indicate that DDX1 is expressed in some of male germ line stem cells in the mouse and that its expression level gradually decreases during spermatogenesis.
Effect of siRNA-mediated knockdown of Ddx1 in a mouse spermatogonia-derived cell line To understand the physiological role of Ddx1 in germ cell maintenance and spermatogenesis in the testis, we introduced an siRNA expression vector for Ddx1 into the mouse spermatogonia-derived cell line GC-1spg (hereafter referred to as GC-1). The morphology and growth rate of GC-1 cells expressing Ddx1-siRNA (designated as siDdx1/GC-1 cells) were not different from those of control GC-1 cells (Figure 2a ), although DDX1 expression was repressed at both the mRNA and protein levels in siDdx1/GC-1 cells (Figure 2b) .
Next, we compared the mRNA expression profiles of siDdx1/GC-1 cells and control GC-1 cells by using mouse cDNA microarrays. The expressions of Neurod6, Itgb7 and Ft11 were downregulated, and Il18, Fabp5 and Xpa were upregulated by Ddx1-knockdown in GC-1 cells (Supplementary Table S1 ). Among these differentially expressed genes, reverse transcriptase (RT)-PCR confirmed that the mRNA expressions of cyclin-D2, GDF3 and CD9 were diminished in siDdx1/GC-1 cells (Figure 2c ). This result is meaningful because cyclin-D2 is amplified in most cases of TGCTs (Houldsworth et al., 1997) and these three genes localize in the stem cell gene cluster at chromosome 12p13.3 in the human (Figure 2d ). In the mouse, cyclin-D2, GDF3 and CD9 are located on chromosome 6.
Transcriptional regulation of cyclin-D2 by DDX1
To exclude any off-target effect of the Ddx1 siRNA, we introduced the pLRT-siRNA R -Ddx1 retroviral vector (Figure 3a) , which contains an siRNA-resistant Ddx1 cDNA under the control of a doxycycline (Dox)-inducible promoter, into siDdx1/GC-1 cells. In this cell (Figure 3b ), demonstrating that DDX1 is a positive regulator of cyclin-D2 expression.
As previous reports have suggested that DEAD-box proteins act as transcriptional activators in some cellular contexts, we generated a luciferase reporter construct driven by an enhancer/promoter region of the mouse cyclin-D2 gene. This construct was transfected into siDdx1/GC-1 cells carrying pLRT-siRNA R -Ddx1, and we compared the reporter activities of Dox-treated and -untreated cells. A genomic DNA region encompassing À445 to þ 275 of the mouse cyclin-D2 gene contained a DDX1-responsive element (Figures 3c and d) . Doxdependent reporter transactivation was also observed in constructs carrying the À385 to þ 275, or À348 to þ 275, region. However, Dox-dependent reporter activity upregulation was canceled when the upstream DNA region was shortened to À308 to þ 275. Moreover, a 2-bp mutation between À348 and À309 (TTT to GTG) disrupted the transactivation of the reporter as well as its Dox-responsiveness ( Figure 3c ). Therefore, the genomic DNA region between À348 and À309 is responsible for the DDX1-mediated transcriptional activation of mouse cyclin-D2.
Binding of DDX1 to a promoter region of cyclin-D2 Based on the interaction between DDX1 and the promoter region of the mouse cyclin-D2 gene, we examined whether DDX1 is present in a putative transcription factor complex that is physically associated with the À348 to À309 region. A nuclear extract from GC-1 cells was subjected to an electrophoretic mobility shift assay (EMSA) with various 32 P-labeled R -Ddx1 pretreated with or without Dox were transfected with a series of reporter plasmids that carried various lengths of genomic DNA fragments for an upstream region of mouse cyclin-D2. Forty-eight hours after transfection, the luciferase activities of the cell lysates were measured and the F/R values were calculated. Each value represents the mean ratio of firefly versus Renilla luciferase activities (F/R) ± s.d. *Po0.01; NS, not significant compared to Dox-untreated cells (n ¼ 3). (d) Nucleotide sequence of the À450 to þ 275 region of mouse cyclin-D2 gene. A DDX1-responsive region is boxed and binding motifs for known transcription factors are indicated by broken lines. Position of translational initiation site is underlined.
Role of DDX1 in testicular tumorigenesis K Tanaka et al double-stranded 20-mer oligonucleotide probes. Although we failed to detect any retarded bands when we used the sequence between À328 and À309 as a probe (data not shown), a slow migrating band was reproducibly detected when the À348 to À329 region was used (Figure 4a ). This band was competed away by the presence of excess cold oligonucleotide, but not by a mutant oligonucleotide with a 4-bp replacement (Figure 4a ). Moreover, part of the band was supershifted when an anti-DDX1 antibody was added to the EMSA reaction mixture. An anti-C/EBPa antibody had no effect on the band mobility, confirming the specificity of the effect of the anti-DDX1 antibody.
Next, we prepared and added a GST-DDX1 fusion protein to the EMSA reaction mixture. The majority of the slowly migrating band was further retarded with GST-DDX1, but not with GST alone (Figure 4b ). GST-DDX1 could interact with the radiolabeled probe in the absence of the GC-1 nuclear extract (Figure 4b) , revealing a direct association between DDX1 and a DNA sequence of the À348 to À329 region. The different band positions of EMSA reactions with GC-1 nuclear extract alone, extract with GST-DDX1 or GST-DDX1 alone suggest that the DDX1-DNA (À348 to À329) complex should contain other nuclear factors, and that endogenous DDX1 is not saturated for complex formation in GC-1 cells.
Finally, chromatin immunoprecipitation (ChIP) assays were employed to examine whether DDX1 is present in a chromatin complex of the mouse cyclin-D2 gene in GC-1 cells. The chromatin fraction of GC-1 cells was immunoprecipitated with an anti-DDX1 antibody or with a control anti-C/EBPa antibody, and was then subjected to genomic DNA PCR. A band of the expected size covering the cyclin-D2 promoter region was detectable only when the anti-DDX antibody was used (Figure 4c ). These results confirmed that DDX1 is associated with the cyclin-D2 promoter region in the nucleus of GC-1 cells.
Effect of siRNA-mediated DDX1 knockdown in a human TGCT cell line In men, the amplification and overexpression of 12p genes, including cyclin-D2, occur in TGCTs at a high frequency. Therefore, we examined the mRNA expression levels of DDX1 and 12p stem cell genes in NEC8, a human embryonal carcinoma-derived cell line, and in siDDX1/NEC8, a derivative cell line expressing a DDX1-specific siRNA. The expression level of the DDX1 protein in siDDX1/NEC8 cells was reduced to one-third of that in NEC8 cells (Figure 5a ). The morphology and growth rate of siDDX1/NEC8 cells were indistinguishable from those of control NEC8 cells ( Figure 5b) . As was the case in GC-1 cells, the mRNA levels of cyclin-D2 and CD9 were decreased in siDDX1/ NEC8 cells compared to parental NEC8 cells (relative level 0.47 or 0.55; Figure 5c , upper), but the level of GDF3 was not severely affected (relative level 0.89).
NANOG and STELLA also map on 12p13.3 as stem cell-associated genes. The relative mRNA level of NANOG in siDDX1/NEC8 cells was decreased to 0.46 compared to NEC8 cells, but the expression of STELLA was comparable to NEC8 cells (relative level 0.94). In contrast, in the colon carcinoma cell line Lovo Figure 4 Interaction of DDX1 with a promoter region of the mouse cyclin-D2 gene. (a) Equal amounts of nuclear protein prepared from GC-1 cells were reacted with radiolabeled oligonucleotide (À348 to À328) in the presence or absence of unlabeled competitor oligonucleotide (matched or mutated). In other cases, an anti-DDX1 or anti-C/EBPa (negative control) antibody was added to the reaction mixture. DNA-protein complex formation was visualized by electrophoretic mobility shift assay (EMSA) followed by autoradiography. The solid and open arrows show a specific complex containing DDX1 and its supershifted complex containing an anti-DDX1 antibody, respectively. (b) Purified GST-DDX1 fusion protein or GST protein was reacted with radiolabeled oligonucleotide (À348 to À328) in the presence or absence of the GC-1 nuclear extract. DNA-protein complex formation was visualized by EMSA followed by autoradiography. Positions of the GST-DDX1-containing complex are shown by solid arrows. (c) The chromatin fraction of the GC-1 cells was immunoprecipitated with an anti-DDX1 or anti-C/EBPa (negative control) antibody and subjected to PCR with primers that detected a proximal promoter region of the mouse cyclin-D2 gene. DNA bands were visualized by ethidium bromide staining.
Role of DDX1 in testicular tumorigenesis K Tanaka et al (Godbout and Squire, 1993) , DDX1 mRNA was abundantly expressed, but GDF3, NANOG and STELLA mRNAs were not detectable (Figure 5c, lower) . Thus, the simultaneous expression of DDX1 and these three 12p genes may be cell-type dependent. It is worth noting that DDX1 knockdown in NEC8 cells reduced the mRNA expression level, not only for 12p genes, but also for many other genes localized on different regions of the human chromosomes (Supplementary Figure S1 and Table S2 ). Presumably, these genes include indirect target genes of DDX1. In a regular culture medium in the presence of 10% fetal calf serum (FCS), the doubling time and saturation density of siDDX1/NEC8 cells were not different from those of control NEC8 cells (Figure 5b ). However, in soft agar medium, the cloning efficiency of siDDX1/NEC8 cells was just 5% that of control NEC8 cells (Figure 5d ).
We performed an in vivo tumorigenesis assay and found that, consistent with previous results (Motoyama et al., 1987) , control NEC8 cells formed palpable tumors in athymic nude mice (4/8) within 2 weeks of subcutaneous injection of 5 Â 10 6 cells. The tumor size in these mice reached 1 cm 3 after 6 weeks. These tumors consisted of cells with large nuclei and an evident loop structure (Figure 5e ). In contrast, mice transplanted with the same number of siDDX1/NEC8 cells developed no tumors, even at 16 weeks postinjection (0/8). These data demonstrate that the tumorigenic capacity of NEC8 cells is abolished by DDX1 knockdown.
Expression of DDX1 mRNA in human TGCT and normal testicular samples To determine whether DDX1 mRNA is produced in human spermatogonial stem cells and TGCT samples, Role of DDX1 in testicular tumorigenesis K Tanaka et al we performed in situ hybridization using testis cancer tissue arrays containing various histological subgroups of TGCTs and adjacent normal testicular regions. In normal testicular regions, the antisense DDX1 RNA probe hybridized to cells located near the basement membrane of the seminiferous tubule (Figure 6a ). Although these cells appeared to include spermatogonial stem cells based on their cell size and location, DDX1 signals were detectable only in a fraction of them, perhaps reflecting their cell cycle status. In contrast, the antisense DDX1 RNA probe hybridized to most of the tumor cells in both the seminoma (Figures 6c and d) and embryonal carcinoma (nonseminoma) (Figures 6e and f) samples. No such signals were detected with a sense DDX1 RNA probe (Figure 6b ), confirming the specificity for DDX1. These results demonstrate that DDX1 is expressed in spermatogonia and spermatocytes, likely including spermatogonial stem cells in the human as in the mouse, and is present in the seminoma and nonseminoma types of TGCTs.
Discussion
In this study, we first identified Ddx1 among the genes expressed in the PGCs, but not the somatic cells, of mouse gonads. Subsequent experiments demonstrated that DDX1 is indispensable for the tumorigenic capacity of a human TGCT (embryonal carcinoma) cell line. Expression of DDX1 was demonstrated in various human TGCTs classified as seminomas or nonseminomas (embryonal carcinoma). Although DDX1 is predominantly expressed in the germ cell compartment in mouse developing gonads and adult testis, it is also produced in mouse embryonic stem cells (K Tanaka, Figure 6 Expression of DDX1 mRNA in human testicular germ cell tumors (TGCTs) and normal testis. Paraffin sections of human TGCTs and normal testicular regions were subjected to in situ hybridization using a digoxigenin-labeled antisense (a, adjacent normal testicular tissue; c, d, seminoma; e, f, embryonal carcinoma) or sense (b, seminoma) RNA probe for DDX1. Positive signals appear as dark purple dots. Original magnification is Â 200.
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K Tanaka et al T Hara, unpublished data). Hence, DDX1 may function in both seminoma and nonseminoma types of TGCTs in humans.
We also presented several lines of evidence supporting the concept that DDX1 directly binds to the promoter region of cyclin-D2, thereby activating its transcription. Using reporter assays in siDdx1/GC-1 cells carrying pLRT-siRNA R -Ddx1, we determined that the À348 to À309 region of the mouse cyclin-D2 promoter is responsible for this DDX1-dependent transcriptional activation. EMSA and ChIP assays revealed that DDX1 specifically binds to the sequence 5 0 -ACGTACACAC CCTTTATGCC-3 0 between À348 and À329 of the cyclin-D2 promoter and forms a complex with other nuclear proteins. Thus, DDX1 serves as a transcriptional activator, at least in GC-1 cells. It was recently reported that DDX1 promotes the proliferation of JC virus through transcriptional activation of its viral promoter (Sunden et al., 2007) . To our knowledge, this is the first definitive report showing that DDX1 functions as a transcriptional activator for mammalian genes.
Ddx1/DDX1-knockdown experiments in both mouse and human germ cell-derived cell lines demonstrated that cyclin-D2, CD9 and GDF3 (or NANOG in the human) were downstream targets of DDX1. In the human, these three stem cell-associated genes are localized on chromosome 12p13.3, whose genes are frequently amplified in TGCTs (Sperger et al., 2003; Korkola et al., 2006) . As the expressions of many non-12p genes were decreased by DDX1-knockdown in NEC8 cells (Supplementary Figure  S1 and Table S2 ), there could be multiple downstream effector molecules that synergistically promote the tumorigenicity of TGCTs.
As the mRNA levels of GDF3 and CD9 were also downregulated by Ddx1 knockdown in GC-1 cells, we searched for the promoter sequences of these two genes in a public mouse database. There are related sequences between À159 and À140 in the GDF3 promoter and À1271 and À1251 in the CD9 promoter. Although there is a consensus binding motif (5 0 -TTTATGC-3 0 ) for CDXA in these regions (Figure 3d ), binding of the purified GST-DDX1 protein with a sequence of À348 to À329 by EMSA ruled out the possibility of an indirect protein-DNA interaction.
Coamplification of DDX1 and the protooncogene MYCN has been demonstrated in both retinoblastoma and neuroblastoma human cell lines (Godbout et al., 1998) . This is because DDX1 maps to chromosome 2p24 and is located 400-kb telomeric to the MYCN gene. However, the prognostic significance of DDX1 amplification has been inconsistently reported as either a trend toward a poorer (Squire et al., 1995) or an improved (Weber et al., 2004) clinical outcome. There are no reports demonstrating that DDX1 is amplified singly or in combination with MYCN in human TGCT samples, although the expression MYCN was detected in seminomas and embryonal carcinomas (Shuin et al., 1994) .
Given that DDX1 is required for the expression of 12p stem cell genes in GC-1 and NEC8 cells, amplification or aberrant overexpression of DDX1 in testicular cells could cause the overexpression of 12p stem cell genes. However, this is unlikely, because the expression level of DDX1 was comparable between spermatogonial stem-like cells in normal human testis and TGCT samples ( Figure 6 ). As only some of the spermatogonial stem-like cells in the human testis express DDX1, the function of DDX1 could be related to the proliferative capacity of testicular tumor cells. This possibility is consistent with the fact that cyclin-D2 is the downstream target of DDX1.
We found that Ddx1 mRNA is expressed in the male germ line stem cell fraction, that is, cKit
þ integrin a6 þ , present in the mouse testis at 7 dpp. At an early stage of spermatogenesis, type A spermatogonial stem cells undergo self-renewal to produce differentiated type A1 spermatogonial cells as daughter cells (de Rooij, 1998) . As previously reported, cyclin-D2 mRNA is more abundantly expressed in the premeiotic stage of the mouse testis at 3 dpp than in the adult mouse testis. In the mouse testis at 3 dpp, cyclin-D2 mRNA is mainly produced in proliferating type A spermatogonial cells and in Sertoli cells (Nakayama et al., 1996) . Other reports have shown that cyclin-D2 is expressed in the spermatogonia at 7-13 dpp, based on immunohistochemical analyses (Chaganti and Houldsworth, 2000) , and that it plays a crucial role in the differentiation of undifferentiated spermatogonial cells to type A1 (Beumer et al., 2000) . In addition, cyclin-D2-deficient male mice display hypoplastic testes and their sperm numbers are reduced to one-third to one-half of those in normal mice (Sicinski et al., 1996) .
In the mouse testis, CD9 is expressed on spermatogonial stem cells (Kanatsu-Shinohara et al., 2004) and is involved in the early pathogenic events of neoplastic germ cell formation (Biermann et al., 2007) . Moreover, CD9 overexpression has been reported in aggressive gastric carcinomas (Hori et al., 2004) and high-grade astrocytic tumors (Kawashima et al., 2002) . Therefore, CD9 could be required for the invasive growth of TGCTs.
In conclusion, our data reveal that DDX1 plays a critical role in the tumorigenicity of human testicular cells, in part by activating cyclin-D2 transcription and enhancing the expression of other 12p stem cell genes. Repression of the DDX1-mediated transcriptional activation of 12p genes would be a novel strategy to circumvent TGCTs. For this purpose, it is necessary to understand the physiological roles of DDX1 in testicular development and spermatogenesis. Genetic studies using conditional knockout mice for the Ddx1 gene would advance our knowledge of this multifunctional nuclear factor.
Materials and methods
Fluorescence activated cell sorting
The gonadal regions of C57BL/6 mouse male embryos (Nihon SLC, Hamamatsu, Japan) at 13.5 dpc were dissected by microsurgery, and a single cell suspension was prepared by incubation with 0.05% trypsin-EDTA in phosphate-buffered saline (PBS; Sigma, St Louis, MO, USA) for 10 min at 37 1C.
Cells (10 7 /ml) were incubated for 30 min on ice with an anti-SSEA-1 antibody (MC-480, Developmental Studies Hybridoma Bank) at 10 mg/ml in PBS containing 5% FCS (Invitrogen, Carlsbad, CA, USA). Next, they were incubated for 30 min on ice with a fluorescein isothiocyanate-conjugated anti-mouse immunoglobulin M antibody (Roche Diagnostics, Indianapolis, IN, USA) at 10 mg/ml in PBS containing 5% FCS. Cells were resuspended in PBS containing 2 mg/ml of propidium iodide (Sigma) and subjected to cell sorting on a FACSVantage (BD Biosciences, San Jose, CA, USA).
To isolate postnatal germ line stem cells and their descendents, cells were prepared from the testes of C57BL/6 mice at 7 dpp as previously described (Fujino et al., 2006) and stained with a biotinylated anti-c-Kit antibody (2B8) (BD Biosciences), fluorescein isothiocyanate-conjugated anti-Thy1 (53-2.1) (BD Biosciences), phycoerythrin-conjugated antiintegrin a6 (GoH3) (Immunotech, Miami, FL, USA), and allophycocyanin-conjugated streptavidin (Molecular Probes, Eugene, OR, USA), followed by cell sorting on a FACSAria (BD Biosciences).
cDNA RDA Total RNAs were prepared from sorted SSEA-1 þ (3.8 Â 10 4 ) and SSEA-1 À (2.2 Â 10 6 ) cells recovered from 90 mouse embryos at 13.5 dpc using TRIzol (Invitrogen). RNA of 200 ng from each sample were reverse transcribed and amplified using a smart PCR cDNA synthesis kit (Clontech, Logan, UT, USA). The DNAs were digested with Sau3A1, ligated with oligonucleotide adaptors (R-Bg/II-12/24, J-Bg/II-12/24) (Hubank and Schatz, 1994) , and subjected to a second PCR amplification. The cDNA RDA was performed with 10 ng of SSEA-1 þ amplicon as a tester and 1 mg of SSEA-1 À amplicon as a driver, according to a previously described method (Tanaka et al., 2002) .
Cell culture and siRNA-mediated repression of Ddx1 mRNA The GC-1 (mouse type-B spermatogonium-derived) and NEC8 (human embryonal carcinoma-derived) cell lines were purchased from American Type Culture Collection (Manassas, VA, USA) and maintained at 37 1C in Dulbecco's modified Eagle's medium containing 10% FCS and 0.5% penicillinstreptomycin (Sigma). To introduce siRNA, we infected GC-1 cells with the pRePS retroviral vector (Fujino et al., 2006) encoding a double-stranded short hairpin RNA, as previously described (Morita et al., 2000) . The sequences of the sense oligonucleotides for siRNA expression were 5 0 -GCTGTGGA GGAGATGGATT-3 0 for the mouse Ddx1 siRNA and 5 0 -GCTGTGGAAGAGATGGATT-3 0 for the human DDX1 siRNA. Infected cells were selected in a growth medium containing 1 mg/ml of puromycin (Sigma) and independent colonies were isolated using penicillin cups.
Reporter assay
For the conditional expression of Ddx1, we inserted an siRNA-resistant Ddx1 cDNA, in which two nucleotides were replaced so as not to affect the amino-acid composition, into the XhoI-NotI site of the pLRT reverse-tetracycline-regulated retroviral vector (Watsuji et al., 1997) . The siDdx1/GC-1 cells were infected with this pLRT-siRNA R -Ddx1 vector and subjected to selection with blasticidin S (10 mg/ml) (Wako, Osaka, Japan). Exogenous Ddx1 mRNA was induced in siDdx1/GC-1 cells carrying pLRT-siRNA R -Ddx1 by the addition of Dox (1 mg/ml).
To construct the reporter plasmid, we obtained DNA fragments covering the À445 to þ 275 region upstream of the transcriptional initiation site of mouse cyclin-D2 (Ensamble Gene ID: ENSMUST: 00000000188) by PCR, using the splenic DNA of a C57BL/6 mouse as a template, and cloned these fragments into the pGL3 basic vector (Promega, Madison, WI, USA). Transfection and luminometry were carried out as previously described (Fujino et al., 2006) . Statistical analysis was performed using an unpaired Student's t-test and Statview J5.0 software (Abacus Concepts, Berkeley, CA, USA). A P-value of o0.05 was considered to be significant.
EMSA
The nuclear extracts of GC-1 cells were prepared (Javed et al., 2001) and binding reactions performed (Fujino et al., 2006) as previously described. The oligonucleotide sequences used in this study were 5 0 -ACGTACACACCCTTTATGCC-3 0 and 5 0 -GGCATAAAGGGTGTGTACGT -3 0 for the radiolabeled probe and matched competitor, and 5 0 -ACGTACAGTCCCA ATATGCC-3 0 and 5 0 -GGCATATTGGGACTGTACGT-3 0 for the mutated competitor. In some samples, 3 ml of a rabbit anti-DDX1 antibody (Bethyl Laboratories Inc., Montgomery, TX, USA) or a rabbit anti-C/EBPa antibody (sc-61) (Santa Cruz Biotechnology Inc., Santa Cruz, CA, USA) were added and further incubated for 30 min at room temperature. Reaction mixtures were separated on a SuperSep 7.5% gel (Wako) and exposed to a BAS cassette 2040 (Fuji Film, Tokyo, Japan), followed by analysis with a BAS-2500 phosphor imager and Image Gauge version 3.2 (Fuji Film). We cloned a DNA fragment encoding the full-length mouse DDX1 protein into pGEX-4T-1 (GE Healthcare, Buckinghamshire, UK). The GST-DDX1 fusion protein and control GST were produced in Escherichia coli BL21 and purified by affinity chromatography on glutathione Sepharose 4B (GE Healthcare), respectively.
Colony assay and in vivo tumor formation assay For the colony assay, 10 4 cells were resuspended in 0.3% top agar medium (2.5 ml) and layered onto 0.5% bottom agarose medium (5 ml) containing 20% FCS in a 60-mm dish. After incubation for 2 weeks, the number of colonies was counted. Tumorigenicity was tested by subcutaneous injection of 5 Â 10 6 cells in 6-week-old athymic nu/nu mice (Nihon SLC). Control NEC8 and siDdx1/NEC8 cells were injected into the right and left chest areas of each mouse (n ¼ 8), respectively. Mice were maintained under a 12-h light, 12-h dark cycle in a pathogenfree animal facility for tumor formation for up to 4 months postinjection. All experimental procedures with mice were preapproved by the Ethical Committee of the Institute.
